oral glp-1 medications fda approved BREAKING: The has the first pill for obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access. The daily pill With FDA approval of Wegovy

When GLP-1 medications slow those natural contractions, insoluble fiber helps compensate by providing the mechanical stimulus your colon needs to keep moving

Regular monitoring during GLP-1 therapy should include assessment of weight loss progress, tolerability, adherence, and screening for adverse effects

Is a maintenance dose the same as a therapeutic dose

Insurance coverage remains inconsistent, with many plans covering the diabetes indication but denying the weight loss indication

Month One to Three: Visible Weight Loss Begins For many patients, months one through three are when visible results become more apparent

If appetite is controlled, weight loss is progressing and side effects at the current dose are acceptable, staying at a dose that is working is a completely reasonable clinical decision